1 Paediatric Neurology Unit, Children's Hospital A. Meyer-University of Florence, 50139, Florence, Italy
2 Department of Functional Neurology and Epileptology, Hospices Civils de Lyon, 69500, Lyon and Lyon 1 University, France 3 Lyon's Research Neuroscience Centre, INSERM U1028/CNRS UMR5292, Lyon, France 4 Epilepsy Institute (IDEE), Lyon, France.
Brain. 2016 Feb;139(Pt 2):444-51. doi: 10.1093/brain/awv372. Epub 2015 Dec 22.
Reasons for failed temporal lobe epilepsy surgery remain unclear. Temporal plus epilepsy, characterized by a primary temporal lobe epileptogenic zone extending to neighboured regions, might account for a yet unknown proportion of these failures. In this study all patients from two epilepsy surgery programmes who fulfilled the following criteria were included: (i) operated from an anterior temporal lobectomy or disconnection between January 1990 and December 2001; (ii) magnetic resonance imaging normal or showing signs of hippocampal sclerosis; and (iii) postoperative follow-up ≥ 24 months for seizure-free patients. Patients were classified as suffering from unilateral temporal lobe epilepsy, bitemporal epilepsy or temporal plus epilepsy based on available presurgical data. Kaplan-Meier survival analysis was used to calculate the probability of seizure freedom over time. Predictors of seizure recurrence were investigated using Cox proportional hazards model. Of 168 patients included, 108 (63.7%) underwent stereoelectroencephalography, 131 (78%) had hippocampal sclerosis, 149 suffered from unilateral temporal lobe epilepsy (88.7%), one from bitemporal epilepsy (0.6%) and 18 (10.7%) from temporal plus epilepsy. The probability of Engel class I outcome at 10 years of follow-up was 67.3% (95% CI: 63.4-71.2) for the entire cohort, 74.5% (95% CI: 70.6-78.4) for unilateral temporal lobe epilepsy, and 14.8% (95% CI: 5.9-23.7) for temporal plus epilepsy. Multivariate analyses demonstrated four predictors of seizure relapse: temporal plus epilepsy (P < 0.001), postoperative hippocampal remnant (P = 0.001), past history of traumatic or infectious brain insult (P = 0.022), and secondary generalized tonic-clonic seizures (P = 0.023). Risk of temporal lobe surgery failure was 5.06 (95% CI: 2.36-10.382) greater in patients with temporal plus epilepsy than in those with unilateral temporal lobe epilepsy. Temporal plus epilepsy represents a hitherto unrecognized prominent cause of temporal lobe surgery failures. In patients with temporal plus epilepsy, anterior temporal lobectomy appears very unlikely to control seizures and should not be advised. Whether larger resection of temporal plus epileptogenic zones offers greater chance of seizure freedom remains to be investigated.
颞叶癫痫手术失败的原因仍不清楚。颞叶加癫痫的特征是原发性颞叶致痫区延伸至邻近区域,可能占这些失败病例的未知比例。在这项研究中,所有符合以下标准的两个癫痫手术项目的患者均被纳入研究:(i) 1990 年 1 月至 2001 年 12 月期间进行的前颞叶切除术或切断术;(ii)磁共振成像正常或显示海马硬化迹象;(iii)术后随访≥24 个月的无癫痫发作患者。根据术前数据,将患者分为单侧颞叶癫痫、双侧颞叶癫痫或颞叶加癫痫。采用 Kaplan-Meier 生存分析计算无癫痫发作的时间概率。采用 Cox 比例风险模型研究癫痫复发的预测因素。在 168 例患者中,108 例(63.7%)行立体脑电图检查,131 例(78%)有海马硬化,149 例为单侧颞叶癫痫(88.7%),1 例为双侧颞叶癫痫(0.6%),18 例为颞叶加癫痫(10.7%)。整个队列 10 年随访的 Engel Ⅰ级结局概率为 67.3%(95%CI:63.4-71.2%),单侧颞叶癫痫为 74.5%(95%CI:70.6-78.4%),颞叶加癫痫为 14.8%(95%CI:5.9-23.7%)。多变量分析显示癫痫复发的四个预测因素:颞叶加癫痫(P<0.001)、术后海马残留(P=0.001)、创伤性或感染性脑损伤史(P=0.022)和继发性全面强直阵挛发作(P=0.023)。与单侧颞叶癫痫相比,颞叶加癫痫患者手术失败的风险增加了 5.06 倍(95%CI:2.36-10.382)。颞叶加癫痫是颞叶手术失败的一个迄今未被认识的重要原因。对于颞叶加癫痫患者,前颞叶切除术极不可能控制癫痫发作,不应建议采用这种方法。是否更大程度地切除颞叶加癫痫区能增加无癫痫发作的机会仍有待研究。